Figure 1.

The Association of TRIP-Brs in Multiple Carcinomas Including Breast Cancer (BRCA)

(A) A significant overexpression was found in most of the cancers, including BRCA patients’ tissue multiple datasets. The mRNA levels and gene rank of TRIP-Brs were also elucidated in BRCA patients’ versus normal breast tissue samples. The datasets were shown with statically significant (p < 0.01) mRNA levels in red and blue. Red, overexpression; blue, downregulated (Oncomine database). (B–F) Differential expression pattern of TRIP-Brs (statistically significant values were indicated in ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001) in multiple carcinoma with adjacent normal tissues.